yahoo_financeOriginal article
Envudeucitinib Long-term Data Positioned to Set a New Standard for Plaque Psoriasis Treatment, Delivering Highest Reported PASI 100 Skin Clearance Among Oral Therapies
Data ReadoutpositiveEnvudeucitinibPositive
AI Analysis
Summary
Envudeucitinib long-term data demonstrates the highest reported PASI 100 skin clearance rate among oral therapies for plaque psoriasis treatment. The results position the therapy as a potential new standard for the indication.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Long-term data showing highest reported PASI 100 skin clearance among oral therapies
Importance:6/10
Sentiment:
0.80
dermatologyoral_therapyefficacy_datalong-term_resultspsoriasis
Related Companies
Read the original article
Published by yahoo_finance on August 10, 2026 8:05 PM